welcome to oneFAPvoice- a positively charged Familial Adenomatous Polyposis community.
- join today!
Sulindac Sulfone is Most Effective in Modulating Beta-Catenin-Mediated Transcription in Cells with Mutant APC
source: Annals of the New York Academy of Sciences
authors: Chang W C, Everley L C, Pfeiffer G R, Cooper H S, Barusevicius A, Clapper M Lsummary/abstract:
Sulindac sulfone (FGN-1, Aptosyn), a metabolite of the nonsteroidal anti-inflammatory drug sulindac, lacks cyclooxygenase inhibitory activity. Although its ability to inhibit tumorigenesis in both carcinogen-treated animals and patients with familial adenomatous polyposis has been attributed to the induction of apoptosis, its complete mechanism of action remains unclear. The purpose of the present study was to determine the ability of sulindac metabolites to regulate cellular levels of beta-catenin and downstream targets of the adenomatous polyposis coli (APC)/beta-catenin pathway in vitro. Sulindac sulfone was consistently more potent than the sulfide metabolite in all analyses, significantly decreasing the expression of total cellular beta-catenin (50% of control), pro-caspase 3 (49%), cyclin D1 (51%), and PPARdelta (65%) in SW480 cells. No significant alteration in pro-caspase 3 or beta-catenin expression was found in HCA7, LS174, or Caco-2 cells treated with sulindac sulfone. A dose-dependent reduction in TCF-mediated transcriptional activity was also observed in SW480 cells. These data demonstrate that sulindac sulfone can modulate the APC/beta-catenin pathway in vitro and that its efficacy is dependent upon the mutational status of APC and beta-catenin.organization: Fox Chase Cancer Center
read more full text source
expertly curated content related to this topic
A Randomized Placebo-Controlled Prevention Trial of Aspirin and/or Resistant Starch in Young People with Familial Ad...Evidence supporting aspirin and resistan...
Hereditary Colorectal Cancer Syndromes: American Society of Clinical Oncology Clinical Practice Guideline Endorsemen...Purpose: To provide recommendations on ...
Hereditary Colorectal Cancer Syndromes: American Society of Clinical Oncology Clinical Practice Guideline Endorsemen...PURPOSE: To provide recommendations on ...
Precancerous Colorectal Lesions (Review)Colorectal cancer (CRC) is a common and ...
Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of...This phase II trial studies the side eff...
Colon Polyps and the Prevention of Colorectal CancerThis book explains colon polyps and thei...
Rectal Proliferation and Polyp Occurrence in Pateints with Familial Adenomatous Polyposis after Sulindac TreatmentBACKGROUND/AIMS : Sulindac, a nonsteroid...